Cite
APA Citation
Kim, H., Liew, D., & Goodall, S. (2020). cost‐effectiveness and financial risks associated with immune checkpoint inhibitor therapy. British journal of clinical pharmacology, 86(9), 1703–1710. http://access.bl.uk/ark:/81055/vdc_100106937850.0x00004a